4
Changes in Ownership
Travere Therapeutics, Inc. Filed Acc 0001415889-25-002001
CHIEF COMMERCIAL OFFICER sold 1,584 shares at $18.94 ($30,002)
From the SEC's structured data for this filing
Trades in this filing
Heerma Peter · CHIEF COMMERCIAL OFFICER
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-22 | Sale : show line 1 in the form | −1,584 | $18.94 | $30,002 | 106,374 | D |
| Open-market sales · 1,584 sh · avg $18.94 · $30,002 | ||||||
Loading xslF345X05/form4-01242025_010141.xml…